Methylprednisolone Recruiting Phase 0 Trials for Raynaud's Phenomenon / Sclerosis, Progressive Systemic Treatment

IndicationsStatusPurposePhase
RecruitingTreatment0
clinicaltrials.gov IdentifierTitleDrugs
NCT03059979The Effect of High Dose Methylprednisolone on Nailfold in Early Systemic Sclerosis ( SSc )